The European TREatment of ATopic eczema (TREAT) Registry Taskforce survey: prescribing practices in Europe for phototherapy and systemic therapy in adult patients with moderate‐to‐severe atopic eczema

BACKGROUND: For many years dermatologists have had access to few therapies for patients with moderate‐to‐severe atopic eczema (AE). New promising therapies are entering the market but conventional phototherapies and systemic therapies have more well‐known safety profiles, lower costs and wider avail...

Descripción completa

Detalles Bibliográficos
Autores principales: Vermeulen, F.M., Gerbens, L.A.A., Schmitt, J., Deleuran, M., Irvine, A.D., Logan, K., Ouwerkerk, W., Vestergaard, C., Flohr, C., Spuls, P.I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754420/
https://www.ncbi.nlm.nih.gov/pubmed/32068893
http://dx.doi.org/10.1111/bjd.18959

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7754420/
https://www.ncbi.nlm.nih.gov/pubmed/32068893
http://dx.doi.org/10.1111/bjd.18959

Ejemplares similares